ClinicalTrials.govpublic full text
Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated
advanced non small cell lung cancer, met exon 14 mutation
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 303739
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.